We are live on
!
Find out more
SAM
Strategy Asset Managers Portfolio holdings
AUM
$650M
Turnover
21.36%
1-Year Est. Return
25.51%
This Fund
S&P 500
This Quarter
Est. Return
+7.9%
1 Year Est. Return
+25.51%
3 Year Est. Return
+115.5%
5 Year Est. Return
+130.94%
10 Year Est. Return
+375.79%
AUM
$556M
AUM Growth
+$20.3M
(+3.8%)
Cap. Flow
-$12.1M
Cap. Flow
% of AUM
-2.18%
Top 10 Holdings %
Top 10 Hldgs %
31.93%
Holding
282
New
42
Increased
89
Reduced
108
Closed
32
Avg Time Held
3.2
years
Top 10 Avg Time Held
3.9
years
Top 20 Avg Time Held
4.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.39M |
| 2 |
iShares Core Universal USD Bond ETF
IUSB
|
+$1.8M |
| 3 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$1.22M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.17M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$6.86M |
| 2 |
Broadcom
AVGO
|
+$3.44M |
| 3 |
NVIDIA
NVDA
|
+$2.78M |
| 4 |
Palantir
PLTR
|
+$2.73M |
| 5 |
Elevance Health
ELV
|
+$2.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.69% |
| 2 | Miscellaneous | 15.49% |
| 3 | Financials | 12.46% |
| 4 | Industrials | 11.59% |
| 5 | Healthcare | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Johnson Controls International
JCI
$89.4B
| $703K | 0.13% |
+6,390
| New | +$683K |
2025 Q3
0 quarters
|
|
127
NiSource
NI
$19.8B
| $699K | 0.13% |
16,135
+16
| +0.1% | +$662 |
2025 Q1
2 quarters
|
|
128
Gilead Sciences
GILD
$195B
| $682K | 0.12% |
+6,148
| New | +$699K |
2025 Q3
0 quarters
|
|
129
iShares Russell 1000 Growth ETF
IWF
$127B
| $662K | 0.12% |
5,656
| – | – |
2022 Q3
12 quarters
|
|
130
iShares US Technology ETF
IYW
$25.8B
| $657K | 0.12% |
3,355
-24
| -0.7% | -$4.39K |
2019 Q4
23 quarters
|
|
131
Jabil
JBL
$30.1B
| $655K | 0.12% |
+3,014
| New | +$656K |
2025 Q3
0 quarters
|
|
132
VeriSign
VRSN
$27.5B
| $654K | 0.12% |
+2,341
| New | +$654K |
2025 Q3
0 quarters
|
|
133
Blackrock
BLK
$174B
| $652K | 0.12% |
559
-20
| -3% | -$22.4K |
2022 Q3
12 quarters
|
|
134
Equifax
EFX
$18.9B
| $646K | 0.12% |
2,518
+5
| +0.2% | +$1.26K |
2024 Q3
4 quarters
|
|
135
CME Group
CME
$104B
| $646K | 0.12% |
+2,389
| New | +$650K |
2025 Q3
0 quarters
|
|
136
Corteva
CTVA
$8.59B
| $627K | 0.11% |
+9,275
| New | +$672K |
2025 Q3
0 quarters
|
|
137
Kroger
KR
$37B
| $617K | 0.11% |
+9,148
| New | +$637K |
2025 Q3
0 quarters
|
|
138
Welltower
WELL
$169B
| $613K | 0.11% |
3,443
-4
| -0.1% | -$657 |
2025 Q1
2 quarters
|
|
139
BlackRock Flexible Income ETF
BINC
$16.5B
| $608K | 0.11% |
11,426
+7,537
| +194% | +$399K |
2025 Q1
2 quarters
|
|
140
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$50.8B
| $599K | 0.11% |
+6,534
| New | +$599K |
2025 Q3
0 quarters
|
|
141
Casey's General Stores
CASY
$24.9B
| $572K | 0.1% |
1,011
| – | – |
2022 Q3
12 quarters
|
|
142
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.32B
| $540K | 0.1% |
3,362
-757
| -18% | -$118K |
2019 Q4
23 quarters
|
|
143
American Express
AXP
$212B
| $528K | 0.1% |
1,590
-1,995
| -56% | -$635K |
2018 Q1
30 quarters
|
|
144
iShares 10-20 Year Treasury Bond ETF
TLH
$11.6B
| $519K | 0.09% |
+5,043
| New | +$510K |
2025 Q3
0 quarters
|
|
145
L3Harris
LHX
$44.8B
| $510K | 0.09% |
1,670
-148
| -8% | -$40.5K |
2022 Q3
12 quarters
|
|
146
Xylem
XYL
$24.1B
| $506K | 0.09% |
3,431
-28
| -0.8% | -$3.88K |
2022 Q3
12 quarters
|
|
147
Schwab US Dividend Equity ETF
SCHD
$114B
| $497K | 0.09% |
18,208
| – | – |
2024 Q3
4 quarters
|
|
148
iShares 0-3 Month Treasury Bond ETF
SGOV
$115B
| $485K | 0.09% |
4,816
-85
| -2% | -$8.55K |
2025 Q2
1 quarter
|
|
149
Simplify MBS ETF
MTBA
$1.02B
| $477K | 0.09% |
9,474
+4,920
| +108% | +$247K |
2025 Q1
2 quarters
|
|
150
Lowe's Companies
LOW
$110B
| $473K | 0.09% |
1,881
+34
| +2% | +$8.35K |
2020 Q2
21 quarters
|
|
Similar funds
BI
GCM
GWAG
BRIM
PPW
OCAM
AAS
TAWM
Strategy Asset Managers's Q3 2025 Portfolio in Review
As of Q3 2025, Strategy Asset Managers held 282 positions worth $556M, up 3.8% from $536M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Strategy Asset Managers's Q3 2025 filing shows 42 new, 89 increased, 108 reduced and 32 closed positions. Its largest new stake was Avantis Emerging Markets Equity ETF: 17,147 shares worth $1.29M. The largest sale was Meta Platforms (Facebook), an estimated $6.86M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Financials.
- Strategy Asset Managers's largest Q3 2025 buy was Avantis Emerging Markets Equity ETF: 17,147 shares worth $1.29M.
- Strategy Asset Managers added most to Eli Lilly in Q3 2025, an estimated $2.39M increase.
- Strategy Asset Managers's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $6.86M.
- Strategy Asset Managers fully exited Elevance Health in Q3 2025, selling an estimated $2.42M.
- Strategy Asset Managers's ten largest holdings make up 32% of its $556M portfolio in Q3 2025.
- Strategy Asset Managers opened 42 new positions and closed 32 in Q3 2025.
- Strategy Asset Managers's portfolio value rose 3.8% quarter-over-quarter to $556M.
Based on Strategy Asset Managers's 13F filing for Q3 2025, filed 4 Nov 2025.